Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Blood Flow in Infants

NCT06646250 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.

NCT NCT06646250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06646250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Blood Flow in Infants
Lead sponsor
St. Olavs Hospital
Phase
Observational
Overall status
Recruiting
Start date
October 20, 2024
Completion date
December 31, 2029
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asphyxia, congenital heart disease, patent ductus arteriosus, preterm, pulmonary hypertension, sepsis, stroke